Legend Biotech Corporatio... (LEGN)
NASDAQ: LEGN
· Real-Time Price · USD
36.33
1.34 (3.83%)
At close: Sep 05, 2025, 11:58 AM
3.83% (1D)
| Bid | 36.28 |
| Market Cap | 3.34B |
| Revenue (ttm) | 797.73M |
| Net Income (ttm) | -325.77M |
| EPS (ttm) | -1.73 |
| PE Ratio (ttm) | -21 |
| Forward PE | 55.31 |
| Analyst | Buy |
| Ask | 36.36 |
| Volume | 624,394 |
| Avg. Volume (20D) | 1,412,006 |
| Open | 35.40 |
| Previous Close | 34.99 |
| Day's Range | 35.40 - 36.34 |
| 52-Week Range | 27.34 - 54.31 |
| Beta | 0.26 |
About LEGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LEGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LEGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Legend Biotech Corporation is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-10.55%
Legend Biotech shares are trading lower following ...
Unlock content with
Pro Subscription
5 months ago
+9.29%
Legend Biotech Corporation shares are trading higher after the company reported better-than-expected Q4 financial results.
2 weeks ago · seekingalpha.com
What Moved Markets This WeekListen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
3 weeks ago · seekingalpha.com
Legend Biotech Corporation (LEGN) Q2 2025 Earnings Call TranscriptLegend Biotech Corporation (NASDAQ:LEGN ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants Alan S. Bash - President of CARVYKTI® Caroline LeCates Paul - Associate Direc...
3 weeks ago · zacks.com
Key Inflation Data in FocusKey Inflation Data in Focus.
